As a member of Medicines Australia, Novo Nordisk has undertaken to
be open and transparent when providing a reportable payment or
transfer of value to a healthcare professional. Reportable payments
or transfers of value are:
Payments for the provision of services such as giving a
lecture, chairing an educational meeting, providing advice as a
member of an Advisory Board or as a Consultant.
accommodation and/or conference registration fees to attend medical
education as part of those services.
Novo Nordisk has prepared the reports for publication in
accordance with the Medicines Australia Code of Conduct, Edition 18
and Australia's Privacy legislation. The reports identify healthcare
professionals by name where their consent has been provided.
From 1 October 2016, reporting these payments has been mandatory -
details will be reported because healthcare professionals should
reasonably expect that all reportable payments or transfers of value
will be disclosed for each healthcare professional, by name.
The reports are designed to be read on this website. They are
also provided as downloadable CSV files.
To comply with our privacy obligations, the reports may be amended
from time to time. The reports contain the most up to date
information. Any use or disclosure of the data by a third party is the
responsibility of that third party, who must comply with the
Australian Privacy Act 1988. For further information about the
details in the reports, please go to medicinesaustralia.com.au.